LifeVantage
May 4, 2023
Salt Lake City, UT, May 4, 2023 --
LifeVantage Corporation reported fiscal third-quarter revenue of 53.7 million dollars for the period ended March 31, 2023, up 7.5 percent from a year earlier, or about 10.4 percent excluding currency. Americas revenue rose 18.2 percent, including a 19.5 percent increase in the United States, while Asia/Pacific and Europe fell 14.2 percent, or about 5.1 percent in constant currency.
Net income was 1.0 million dollars, or 0.08 dollars per diluted share, compared with 0.09 dollars a year earlier. Adjusted EBITDA was 3.3 million dollars. Active accounts fell 5.1 percent to 149,000. Cash was 19.5 million dollars with no debt. The board raised the quarterly dividend 16.7 percent to 0.035 dollars per share payable June 15, 2023.
President and chief executive Steve Fife said LV360 initiatives, including the Evolve compensation plan, and TrueScience Liquid Collagen momentum drove the acceleration. Fiscal 2023 guidance is revenue of 209 million to 212 million dollars, adjusted EBITDA of 11 million to 13 million dollars, and adjusted EPS of 0.20 to 0.26 dollars.